|
Guest
|
Most recent articles on angiogenesis in lung cancer:
Inhibition of cell proliferation, migration and invasion by DNAzyme
targeting MMP-9 in A549 cells.
Yang L, Zeng W, Li D, Zhou R.
Oncol Rep. 2009 Jul;22(1):121-6.
Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer
xenografts with a reduction in vascular endothelial growth factor.
Soto-Pantoja DR, Menon J, Gallagher PE, Tallant EA.
atallant at (no spam) wfubmc.edu
Mol Cancer Ther. 2009 Jun;8(6):1676-83.
Cellular source and amount of vascular endothelial growth factor and
platelet-derived growth factor in tumors determine response to
angiogenesis inhibitors.
Sennino B, Kuhnert F, Tabruyn SP, Mancuso MR, Hu-Lowe DD, Kuo CJ,
McDonald DM.
barbara.sennino at (no spam) ucsf.edu
Cancer Res. 2009 May 15;69(10):4527-36.
Endostar, a modified endostatin inhibits non small cell lung cancer
cell in vitro invasion through osteopontin-related mechanism.
Ni Q, Ji H, Zhao Z, Fan X, Xu C.
Eur J Pharmacol. 2009 Jul 1;614(1-3):1-6.
An orthotopic endometrial cancer mouse model demonstrates a role for
RUNX1 in distant metastasis.
Doll A, Gonzalez M, Abal M, Llaurado M, Rigau M, Colas E, Monge M,
Xercavins J, Capella G, Diaz B, Gil-Moreno A, Alameda F, Reventos J.
Int J Cancer. 2009 Jul 15;125(2):257-63.
Emerging data with antiangiogenic therapies in early and advanced non-
small-cell lung cancer.
Horn L, Sandler AB.
Clin Lung Cancer. 2009 Mar;10 Suppl 1:S7-16.
Combined inhibition of vascular endothelial growth factor and
epidermal growth factor signaling in non-small-cell lung cancer
therapy.
Pakkala S, Ramalingam SS.
Clin Lung Cancer. 2009 Mar;10 Suppl 1:S17-23.
InTextoResearch, Baelen, Liège, Wallonie (Wallonia), Belgique
(Belgium) & Agence Wallonne d’Information Scientifique (AWIS) (Marc
Lacroix, scimedweb at (no spam) mail.com) |
|
|
